Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kowa
Nagoya, Aichi, Japankowa.co.jp ↗
- Ownership
- Private
- Employees
- ~8074
- Development stage
- Other
01
Overview
Kowa has several commercialized therapies in the cardiovascular/metabolic space, including statins and other lipid-lowering agents; it is active in both clinical development and commercialization internationally, with a long-standing track record and presence in global cardiovascular and metabolic disease R&D and marketed products[5][6][7].
- Therapeutic areas
- ImmunologyCardiovascularOphthalmologyEndocrinologyNeurologyDermatologyOncology
- Modalities
- Small moleculeBiologicDevice
- Industry
- Pharma
02
Partnerships
Nicox S.A. (for NCX 470 licensing)[5]Brigham and Women’s Hospital, Harvard University (Center for Interdisciplinary Cardiovascular Sciences CICS)[5][7]
Beyond the preview
Go deeper on Kowa.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kowa.